287 related articles for article (PubMed ID: 31065564)
1. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
[TBL] [Abstract][Full Text] [Related]
2. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
[TBL] [Abstract][Full Text] [Related]
3. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
[TBL] [Abstract][Full Text] [Related]
5. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
[TBL] [Abstract][Full Text] [Related]
6. Chronic active Epstein-Barr virus infection progresses to aggressive NK cell leukemia with a poor prognosis.
Hu X; Yang Y; Chen L; Wan Y; Sheng L; Bao Y; Zheng M
Am J Transl Res; 2021; 13(10):12006-12015. PubMed ID: 34786135
[TBL] [Abstract][Full Text] [Related]
7. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.
Kimura H; Fujiwara S
Front Pediatr; 2018; 6():417. PubMed ID: 30662890
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.
Wongwiwat W; Fournier B; Bassano I; Bayoumy A; Elgueta Karstegl C; Styles C; Bridges R; Lenoir C; BoutBoul D; Moshous D; Neven B; Kanda T; Morgan RG; White RE; Latour S; Farrell PJ
J Virol; 2022 Jun; 96(12):e0039422. PubMed ID: 35612313
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
Arai A
Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF
J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
Front Pediatr; 2019; 7():71. PubMed ID: 30931288
[TBL] [Abstract][Full Text] [Related]
12. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
Chuang SS
Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
16. Current research on chronic active Epstein-Barr virus infection in Japan.
Fujiwara S; Kimura H; Imadome K; Arai A; Kodama E; Morio T; Shimizu N; Wakiguchi H
Pediatr Int; 2014 Apr; 56(2):159-66. PubMed ID: 24528553
[TBL] [Abstract][Full Text] [Related]
17. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
18. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
[TBL] [Abstract][Full Text] [Related]
19. [Epstein-Barr virus infection and lymphoproliferative disorders].
Isobe Y
Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
[TBL] [Abstract][Full Text] [Related]
20. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
